000 | 01931 a2200517 4500 | ||
---|---|---|---|
005 | 20250518013830.0 | ||
264 | 0 | _c20200507 | |
008 | 202005s 0 0 eng d | ||
022 | _a1097-4652 | ||
024 | 7 |
_a10.1002/jcp.27793 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhou, Yihong | |
245 | 0 | 0 |
_aMRS1754 inhibits proliferation and migration of bladder urothelial carcinoma by regulating mitogen-activated protein kinase pathway. _h[electronic resource] |
260 |
_bJournal of cellular physiology _c07 2019 |
||
300 |
_a11360-11368 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetamides _xpharmacology |
650 | 0 | 4 |
_aAdenosine A2 Receptor Agonists _xpharmacology |
650 | 0 | 4 |
_aAdenosine A2 Receptor Antagonists _xpharmacology |
650 | 0 | 4 |
_aAminopyridines _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xbiosynthesis |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aPurines _xpharmacology |
650 | 0 | 4 |
_aReceptor, Adenosine A2B _xdrug effects |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aUrothelium _xpathology |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xbiosynthesis |
700 | 1 | _aChu, Xi | |
700 | 1 | _aYi, Ye | |
700 | 1 | _aHao, Zheng | |
700 | 1 | _aZheng, Xiaoping | |
700 | 1 | _aYuxin, Tang | |
700 | 1 | _aDai, Yingbo | |
773 | 0 |
_tJournal of cellular physiology _gvol. 234 _gno. 7 _gp. 11360-11368 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcp.27793 _zAvailable from publisher's website |
999 |
_c29178397 _d29178397 |